Related Experiment Video
Updated: Aug 5, 2026

09:51
The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Gluteal Undersurface Concealed Crescent Injury Endoscopic Deep Surface Repair
Bryant P Elrick1, Judas Z Kelley2,3, Eric Welder2,3
1Department of Orthopedics University of Colorado Aurora Colorado U.S.A.
Arthroscopy Techniques
|July 25, 2026
Summary
Gluteal undersurface concealed crescent injury lesions cause significant pain. A novel GUCCI-X technique using knotless anchors offers a tissue-sparing endoscopic repair for these gluteus medius and minimus tears.
Area of Science:
- Orthopedic Surgery
- Sports Medicine
- Minimally Invasive Procedures
Background:
- Partial-thickness articular-sided gluteus medius/minimus tears (gluteal undersurface concealed crescent injury lesions) are a source of debilitating hip pain.
- Nonoperative management often fails, necessitating surgical intervention for persistent symptoms.
Purpose of the Study:
- To describe a novel, tissue-sparing endoscopic surgical technique for repairing gluteal undersurface concealed crescent injury lesions.
- To introduce the "X-linked" compressive configuration (GUCCI-X) using all-suture knotless anchors.
Main Methods:
- The technical note details a minimally invasive endoscopic approach for gluteal tear repair.
- It utilizes all-suture knotless anchors in an "X-linked" compressive configuration (GUCCI-X).
- This technique avoids tendon splitting and knot tying associated with conventional methods.
Main Results:
- The GUCCI-X technique is presented as a tissue-sparing alternative to traditional transtendinous repairs.
- It aims to reduce postoperative pain and irritation.
- Potential for shorter operative and recovery times is implied.
Conclusions:
- The GUCCI-X technique represents an advancement in endoscopic repair for partial-thickness gluteal tears.
- This knotless, tissue-sparing approach may improve patient outcomes and recovery.
- Further studies are warranted to evaluate clinical efficacy.